|
||
![]() |
||||
|
||||
|
Sharon Finch started Medius in 1996 and has almost 30 years international experience in business development in multinational, small pharma and Japanese companies. |
|
Roger Davies previously Director of Business Development at Bioglan and Mundipharma, Roger specialises in clinical stage deals and product/corporate acquisitions and deal valuations. |
|
Bridget Lacey has recently started working with Medius and brings 14 years of corporate finance and business development experiences from the Healthcare industry in Pharmaceuticals, Vaccines and Life Sciences roles in the UK, Singapore and Japan. |
|
Jill Ogden has over 21 years’ experience in the biopharmaceuticals and healthcare industries. Jill provides our drug delivery expertise where she combines commercial experience with a strong scientific background. |
|
Alan Warrander has recently started working with Medius and has over 25 years in-depth industry experience having worked with AstraZeneca and as a Consultant with WoodMackenzie. |
|
Christi Mitchell provides expertise in the acquisition of intellectual Property Rights and in the licensing out of technologies. |
|
John Ansell focuses on international projects that are commercial and strategic, reflecting his previous industry marketing and business development experience. |
|
Linda Sterrett is our Office Director and also is responsible for the management of our Training programmes. Linda has worked with Medius for over 10 years and provides logistical support for our executive team. |
|
Stuart Wren based in San Francisco, advises on corporate development strategy and on alliances. Stuart also has extensive experience in Japan where he was Director of Business Development for GSK. |
|
Sheila Chalmers directs our in depth market intelligence services as well as researching and writing analytical and medical reports. |
|
Andrea Tobias has 13 years in VC and 10 years in the biotech industry and brings technical and strategic development expertise to the team. |
|
Neil Rogers is an experienced marketeer, with extensive pharmaceutical marketing and market research management experience, particularly at the strategic / portfolio level. He has recently left AstraZeneca, after 25 years, and works with a number of Biopharmaceutical clients advising them on CI and MR processes and techniques, running strategic workshops and “War Games”, along with supporting new product evaluations. |